Kymera Therapeutics
Utility Patent Applications
Last updated:
List of all Kymera Therapeutics patents 12 in total
| Status | Patent |
|---|---|
Application | Utility: FUSED-GLUTARIMIDE CRBN LIGANDS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: IRAK4 DEGRADERS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: IRAK4 DEGRADERS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 1 Sep 2022 |
Application | Utility: METHODS OF TREATING MUTANT LYMPHOMAS Filling date: 7 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: CRYSTALLINE FORMS OF IRAK DEGRADERS Filling date: 7 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: IRAK DEGRADERS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: PROTEIN DEGRADERS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 5 Aug 2021 |
Application | Utility: IRAK DEGRADERS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: PROTEIN DEGRADERS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: CRBN LIGANDS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: CRBN LIGANDS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: TRICYCLIC CRBN LIGANDS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 9 Jan 2020 |
Showing 1 to 12 of 12 patents.